At Zasya Life Sciences, we offer a comprehensive range of analytical solution. Our experienced analytical team provides tailored solutions for every stage of drug development, from early-phase research to commercial production.
We develop and validate robust analytical methods for small molecules, Peptides, API intermediates and APIs
We specialize in impurity identification, isolation, and characterization.
We conduct stability studies following ICH guidelines under long-term, intermediate, and accelerated conditions.
We perform degradation studies to demonstrate the specificity and robustness of analytical methods under various degradation conditions (acidic, basic, thermal, etc.).
We generate and qualify reference standards, ensuring their potency, identity, and purity through techniques such as NMR, HRMS, HPLC and FT-IR.
Analytical methods for critical quality attributes (CQAs) are developed in line with process development, including verification of methods for assays, related substances, and residual solvents.
We use HRMS, NMR, and HPLC for thorough impurity profiling, ensuring that all impurities are identified, isolated, and characterized to meet regulatory requirements.
We analyze polymorphic forms to ensure product consistency and performance.
Our facilities support a range of climatic conditions for stability studies, meeting regulatory requirements.
